T
Timothy L. Ratliff
Researcher at Purdue University
Publications - 312
Citations - 20541
Timothy L. Ratliff is an academic researcher from Purdue University. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 69, co-authored 306 publications receiving 19092 citations. Previous affiliations of Timothy L. Ratliff include University of Iowa Hospitals and Clinics & Beth Israel Deaconess Medical Center.
Papers
More filters
Journal ArticleDOI
Daily stress and symptom exacerbation in interstitial cystitis patients
TL;DR: It is indicated that life stress is associated with greater IC symptoms, particularly among patients whose disease is not well controlled.
Journal ArticleDOI
Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer.
Jie Li,Ruixin Wang,Yifan Kong,Meaghan M. Broman,Colin Carlock,Long Chen,Zhiguo Li,Elia Farah,Timothy L. Ratliff,Xiaoqi Liu +9 more
TL;DR: Findings implicate the critical role of Plk1 in PARPi resistance in BRCA-mutant CRPC cells, and shed new light on the treatment of non-BRCA–mutant patient subgroups who might also respond favorably to PARPi.
Journal ArticleDOI
Interferon induction and augmentation of natural-killer activity by Staphylococcus protein A.
TL;DR: Protein A from Staphylococcus aureus-induced interferon (IF) production and augmented natural-killer (NK) activity in human peripheral blood mononuclear cells (PBL) correlated directly with IF production.
Journal ArticleDOI
Functionalized NIR-II Semiconducting Polymer Nanoparticles for Single-cell to Whole-Organ Imaging of PSMA-Positive Prostate Cancer.
Jiayingzi Wu,Jiayingzi Wu,Hyeon Jeong Lee,Liyan You,Xuyi Luo,Tsukasa Hasegawa,Kai-Chih Huang,Peng Lin,Timothy L. Ratliff,Minoru Ashizawa,Jianguo Mei,Ji-Xin Cheng +11 more
TL;DR: BTII-DUPA SPN is demonstrated as a promising probe for prostate cancer diagnosis by PA tomographic imaging in the NIR-II window, allowing noninvasive PA detection of PSMA overexpressing prostate tumors in vivo.
Journal ArticleDOI
Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes
TL;DR: It is found that CD154 is abundantly expressed in platelet precursor cells, megakaryocytes, and this work suggests that platelet-associated CD154 can be biochemically modulated.